Measurement Of Circulating Tumor Dna (ctdna) - Cancer Science

Relevant Publications

Exploring the biology of ctDNA release in colorectal cancer.

Issue Release: 2024

Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers.

Issue Release: 2024

The prognostic role of circulating tumor DNA across breast cancer molecular subtypes: A systematic review and meta-analysis.

Issue Release: 2024

Variant Allele Frequency Analysis of Circulating Tumor DNA as a Promising Tool in Assessing the Effectiveness of Treatment in Non-Small Cell Lung Carcinoma Patients.

Issue Release: 2024

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma.

Issue Release: 2024

Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis.

Issue Release: 2024

Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer.

Issue Release: 2024

Clinical Validation of Mathematically Derived Early Tumor Dynamics for Solid Tumors in Response to Durvalumab.

Issue Release: 2024

Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer.

Issue Release: 2024

Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.

Issue Release: 2024

Temporal dynamics of RAS mutations in circulating tumor DNA in metastatic colorectal cancer: clinical significance of mutation loss during treatment.

Issue Release: 2024

Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease Assay.

Issue Release: 2024

Circulating tumor DNA predicts venous thromboembolism in patients with cancers.

Issue Release: 2024

Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy.

Issue Release: 2023

Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.

Issue Release: 2023

Response Evaluation of Neoadjuvant Therapies in Sarcoma.

Issue Release: 2023

Circulating Tumor DNA Profiling Approach Based on In Silico Background Elimination Guides Chemotherapy in Nasopharyngeal Carcinoma.

Issue Release: 2023

Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer.

Issue Release: 2023

Single-Droplet Microsensor for Ultra-Short Circulating EFGR Mutation Detection in Lung Cancer Based on Multiplex EFIRM Liquid Biopsy.

Issue Release: 2023

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.

Issue Release: 2023

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Partnered Content Networks

Relevant Topics